• Please log in or register to access this feature.

Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection

  1. F. Ginevri1,*,
  2. A. Nocera2,
  3. P. Comoli3,
  4. A. Innocente4,
  5. M. Cioni1,
  6. A. Parodi5,
  7. I. Fontana2,
  8. A. Magnasco1,
  9. A. Nocco4,
  10. A. Tagliamacco2,
  11. A. Sementa6,
  12. P. Ceriolo6,
  13. L. Ghio7,
  14. M. Zecca3,
  15. M. Cardillo4,
  16. G. Garibotto8,
  17. G. M. Ghiggeri1,
  18. F. Poli4

Article first published online: 7 SEP 2012

DOI: 10.1111/j.1600-6143.2012.04251.x

Issue

American Journal of Transplantation

American Journal of Transplantation

Volume 12, Issue 12, pages 3355–3362, December 2012

Additional Information

How to Cite

Ginevri, F., Nocera, A., Comoli, P., Innocente, A., Cioni, M., Parodi, A., Fontana, I., Magnasco, A., Nocco, A., Tagliamacco, A., Sementa, A., Ceriolo, P., Ghio, L., Zecca, M., Cardillo, M., Garibotto, G., Ghiggeri, G. M. and Poli, F. (2012), Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection. American Journal of Transplantation, 12: 3355–3362. doi: 10.1111/j.1600-6143.2012.04251.x

Author Information

  1. 1

    Pediatric Nephrology, Istituto G. Gaslini, Genova, Italy

  2. 2

    Department of Transplant Surgery, IRCCS Azienda Ospedaliera Universitaria S.Martino-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

  3. 3

    Pediatric Hematology/Oncology, Fondazione Policlinico S. Matteo, Pavia, Italy

  4. 4

    Transplantation Immunology, Fondazione Cà Granda Ospedale Maggiore Policlinico, Milano, Italy

  5. 5

    Nephrology Unit, Ospedale Presidio di Sestri Levante, Genova, Italy

  6. 6

    Pathology, Istituto G. Gaslini, Genova, Italy

  7. 7

    Pediatric Nephrology, Fondazione Cà Granda Ospedale Maggiore Policlinico, Milano, Italy

  8. 8

    Department of Internal Medicine, University of Genova, IRCCS Azienda Ospedaliera Universitaria S. Martino Hospital-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

* Fabrizio Ginevri, fabrizioginevri@ospedale-gaslini.ge.it

  1. Correction made after online publication September 7, 2012: author affiliations have been updated.

Publication History

  1. Issue published online: 30 NOV 2012
  2. Article first published online: 7 SEP 2012
  3. Received 11 June 2012, revised 13 July 2012 and accepted for publication 23 July 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (716K)

Table S1: Characteristics of HLA antibodies in the 13 patients developing DSA only

Table S2: Characteristics of HLA antibodies in the six patients developing DSA and NDSA

Table S3: Characteristics of HLA antibodies in the 18 patients developing NDSA only

Table S4: Pathological findings of biopsies performed in DSA patients

Table S5: Pathological findings of biopsies performed in NDSA patients

FilenameFormatSizeDescription
AJT_4251_sm_suppmat.doc384KSupporting info item

Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

View Full Article with Supporting Information (HTML) Get PDF (716K)